Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Arca

Showing results (131-140 of 212) with videos related to

Pageof 22
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 2, 2018
Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experienceSimona Sperlongano, Felice Gragnano, Francesco Natale, et al.
Journal of Clinical Lipidology|April 2, 2024
Corrigendum to "Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial" [Journal of Clinical Lipidology, Volume 17, Issue 3, May-June 2023, Pages 342-355]Joseph L Witztum, Daniel Gaudet, Marcello Arca, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2014
Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell responseFabrizio Conti, Francesca Romana Spinelli, Cristiano Alessandri, et al.
La Radiologia Medica|March 6, 2023
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography studyFederica Catapano, Nicola Galea, Giacomo Pambianchi, et al.
Journal of Clinical Lipidology|April 26, 2023
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trialJoseph L Witztum, Daniel Gaudet, Marcello Arca, et al.
Journal of Lipid Research|March 30, 2017
Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiencyMonica Gomaraschi, Alice Ossoli, Samuela Castelnuovo, et al.
Atherosclerosis|March 8, 2025
The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg?Daniele Tramontano, Laura D'Erasmo, Miriam Larouche, et al.
Scientific Reports|November 19, 2017
PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stressGuido Carpino, Daniele Pastori, Francesco Baratta, et al.
European Journal of Human Genetics : EJHG|September 16, 2004
The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivityRaffaella Buzzetti, Antonio Petrone, Maria Cristina Ribaudo, et al.
Journal of Clinical Lipidology|November 10, 2021
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosisAlessia Di Costanzo, Ilenia Minicocci, Laura D'Erasmo, et al.
Pageof 22

Showing results (131-140 of 212) with videos related to

Sort By:
Pageof 22
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 2, 2018
Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experienceSimona Sperlongano, Felice Gragnano, Francesco Natale, et al.
Journal of Clinical Lipidology|April 2, 2024
Corrigendum to "Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial" [Journal of Clinical Lipidology, Volume 17, Issue 3, May-June 2023, Pages 342-355]Joseph L Witztum, Daniel Gaudet, Marcello Arca, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2014
Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell responseFabrizio Conti, Francesca Romana Spinelli, Cristiano Alessandri, et al.
La Radiologia Medica|March 6, 2023
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography studyFederica Catapano, Nicola Galea, Giacomo Pambianchi, et al.
Journal of Clinical Lipidology|April 26, 2023
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trialJoseph L Witztum, Daniel Gaudet, Marcello Arca, et al.
Journal of Lipid Research|March 30, 2017
Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiencyMonica Gomaraschi, Alice Ossoli, Samuela Castelnuovo, et al.
Atherosclerosis|March 8, 2025
The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg?Daniele Tramontano, Laura D'Erasmo, Miriam Larouche, et al.
Scientific Reports|November 19, 2017
PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stressGuido Carpino, Daniele Pastori, Francesco Baratta, et al.
European Journal of Human Genetics : EJHG|September 16, 2004
The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivityRaffaella Buzzetti, Antonio Petrone, Maria Cristina Ribaudo, et al.
Journal of Clinical Lipidology|November 10, 2021
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosisAlessia Di Costanzo, Ilenia Minicocci, Laura D'Erasmo, et al.
Pageof 22